EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Application of FreezeTB, a targeted nanopore sequencing assay, for identification of drug resistance and lineages among pulmonary tuberculosis cases in Alaska

Bryce Inman, Jeremy Butler, Soren George-Nichol, Ganna Kovalenko, Theresa Savidge, Yvette Vergnetti, Catherine Pongratz, Elizabeth Bee, Andrew R DiNardo, Alexander Kay, Anna Mandalakas, Eric Bortz iD und 1 weitere

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.02335-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Bryce Inman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Alaska, Anchorage, Alaska, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents, Tuberculosis, Pulmonary, Nanopore Sequencing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, FIC NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alaska has the highest incidence of tuberculosis (TB) in the United States, with 8% mortality while undergoing TB treatment. With a quarter of TB cases lacking sputum culture to enable drug resistance testing, FreezeTB aimed to develop tools tailored to meet the challenges in Alaska while being translatable to other settings. We designed a rapid and cost-effective laboratory workflow and software to identify drug-resistant mutations in Mycobacterium tuberculosis using targeted next-generation sequencing (tNGS). FreezeTB, a Fast, Reliable, Economical Evaluation tool to Zap Endemic Tuberculosis, amplifies 22 gene loci associated with resistance to 16 anti-tuberculosis drugs. M. tuberculosis isolates from Alaska (2011–2024) were blinded and underwent analysis with FreezeTB, then compared with phenotypic drug susceptibility testing (pDST) and whole genome sequencing (WGS). Compared with WGS ( n = 79), FreezeTB provided the same mutations in 96% ( n = 76/79) of samples with 100% lineage agreement ( n = 79/79). Compared with pDST using Cohen’s kappa, FreezeTB had almost perfect agreement for rifampin (RIF, 0.90; n = 97/98) and ethambutol (EMB, 1.00; n = 98/98), strong agreement for isoniazid (INH, 0.80; n = 88/98), moderate agreement for ethionamide (ETO, 0.78; n = 95/98), weak agreement for streptomycin (STR, 0.56; n = 95/98), and no agreement for pyrazinamide (PZA, 0.20; n = 91/98). Using a portable nanopore sequencer, each sample cost under $30 for sequencing, which included a flow cell, a barcoding kit, a flow cell wash kit, a polymerase, and primers. FreezeTB provides a portable, 1-day laboratory and bioinformatic workflow for sequencing M. tuberculosis . Freeze TB can accurately determine mycobacterial lineage and resistance for RIF, INH, ETH, and ETO at a low cost. IMPORTANCE Globally, tuberculosis is the leading infectious cause of mortality with 10.8 million new cases and 1.25 million deaths occurring in 2024. Targeted next-generation sequencing (tNGS) is a rapid, cost-effective method for identifying mutations in the Mycobacterium tuberculosis genome associated with drug resistance. FreezeTB was created to provide low-cost, portable sequencing and tNGS analysis for drug resistance. FreezeTB selectively amplifies and sequences 24 targets of the M. tuberculosis genome that cover regions the WHO has designated as containing mutations conferring drug resistance, as well as provides species confirmation and rapid lineage determination. Freeze TB is a laboratory workflow and free, open-source (OS) low dependency bioinformatic software that can be downloaded onto a computer with no further need for internet access. Using M. tuberculosis isolates from Alaska, FreezeTB provided the same mutations in 96% ( n = 76/79) of samples with 100% lineage agreement ( n = 79/79) compared with whole genome sequencing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisAntitubercular AgentsTuberculosis, PulmonaryNanopore SequencingTuberculosis, Multidrug-ResistantHumansAlaskaMicrobial Sensitivity TestsMutationWhole Genome SequencingHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

AMRAlaskaDR-TBMDR-TBMycobacterium tuberculosisTBnanoporesequencingspoligotypingtNGStargetedtuberculosis

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Biological Sciences, University of Alaska, Anchorage, Alaska, USA.
  • College of Fisheries and Ocean Sciences, University of Alaska, Fairbanks, Alaska, USA.
  • Wen School of Public Health, University of California, Irvine, California, USA.
  • Alaska TB Program, Division of Public Health, Alaska Department of Health, Anchorage, Alaska, USA.
  • Global Tuberculosis Program, Baylor College of Medicine, Houston, Texas, USA.
  • Radboud University, Nijmegen, the Netherlands.

ORCID-Profile: Eric Bortz, Tara E Ness

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • FIC NIH HHS
  • St. Judes/Pediatric Infectious Disease Society
  • Thrasher Research Fund
  • NICHD NIH HHS
  • NIGMS NIH HHS
  • NIGMS IDeA Alaska INBRE

Zitieren

APA

Inman, B., Butler, J., George-Nichol, S., Kovalenko, G., Savidge, T., Vergnetti, Y., Pongratz, C., Bee, E., DiNardo, A. R., Kay, A., Mandalakas, A., Bortz, E., & Ness, T. E. (2026). Application of FreezeTB, a targeted nanopore sequencing assay, for identification of drug resistance and lineages among pulmonary tuberculosis cases in Alaska. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02335-25

Vancouver

Inman B, Butler J, George-Nichol S, Kovalenko G, Savidge T, Vergnetti Y, et al. Application of FreezeTB, a targeted nanopore sequencing assay, for identification of drug resistance and lineages among pulmonary tuberculosis cases in Alaska. Microbiology Spectrum. 2026. doi:10.1128/spectrum.02335-25

BibTeX
@article{Inman2026,
  author = {Inman, Bryce and Butler, Jeremy and George-Nichol, Soren and Kovalenko, Ganna and Savidge, Theresa and Vergnetti, Yvette and Pongratz, Catherine and Bee, Elizabeth and DiNardo, Andrew R and Kay, Alexander and Mandalakas, Anna and Bortz, Eric and Ness, Tara E},
  title = {Application of FreezeTB, a targeted nanopore sequencing assay, for identification of drug resistance and lineages among pulmonary tuberculosis cases in Alaska},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.02335-25}
}
Kostenlos starten →